Belite Bio, Inc American Depositary Shares (BLTE) is a publicly traded Healthcare sector company. As of May 20, 2026, BLTE trades at $144.59 with a market cap of $5.71B and a P/E ratio of 0.00. BLTE moved +2.84% today. Year to date, BLTE is -12.29%; over the trailing twelve months it is +114.92%. Its 52-week range spans $43.70 to $200.00. Analyst consensus is strong buy with an average price target of $215.29. Rallies surfaces BLTE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Belite Bio, Inc American Depositary Shares (BLTE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BLTE moved +2.84% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $144.59 |
| Market Cap | $5.71B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $200.00 |
| 52-Week Low | $43.70 |
| Volume | 100.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
7 analysts cover BLTE: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $215.29.